Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


AAA names apoints four board members

This article was originally published in Scrip

Executive Summary

Saint-Genis-Pouilly, France-based Advanced Accelerator Applications, a specialist company developing molecular nuclear medicines, has named four industry experts to its board of directors. They are: Dr Yvonne Greenstreet, who was a senior vice-president and the head of medicines development at Pfizer from 2010 to 2013. Dr Greenstreet also currently serves on the advisory board of the Bill and Melinda Gates Foundation and as a member of the board of directors of Pacira. Also joining the board is Steve Gannon, a senior vice-president, chief financial officer and treasurer at Aptalis Pharma; Leopoldo Zambeletti, an independent strategic advisor to life science companies on Merger and Acquisitions, out-licensing deals and financing strategy; and Christian Merle, a managing partner at Merle & Partners, advisory.

You may also be interested in...

Building The Talent Pipeline Starts With Access For All

Diversity in all forms is critical to innovation in health care, says AstraZeneca’s chief medical officer, Ann Taylor. In an exclusive interview, she talks about the company’s work in mentoring and education, and why tackling issues around diversity and inclusion must be driven by the C-suite alongside community initiatives. 

Snapshot: October Highlights

A selection of articles you might have missed from October 2020, including exclusive interviews with industry leaders and a deeper dive into the Femtech market.

Execs On The Move, Oct 2020

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts